Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
KT5823 (0.12 g/L), the PKG inhibitor, was injected in lateral ventricular space 1 hour before onset of reperfusion in transient MCAO (tMCAO) and 1 hour after onset of ischemia in pMCAO
This is almost 8% higher than GLP-1s alone
This is great for weight loss and managing blood sugar, but it can also slow things down too much for some people
It carries minimal hypoglycemia risk when used without other glucose-lowering drugs, making it one of the safest glucose-management options available
My ALT was elevated at first, but with better hydration and nutrition, my levels improved." "I started tracking my blood work every 3 months on GLP-1, and I noticed my electrolyte levels were off